Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Stanford University
Ohio State University Comprehensive Cancer Center
Eilean Therapeutics
Stanford University
University of Arizona
National Institutes of Health Clinical Center (CC)
Enliven Therapeutics
University of Kansas Medical Center
Crossbow Therapeutics, Inc.
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
MacroGenics
University of Chicago
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
University of Arizona
Ascentage Pharma Group Inc.
Dana-Farber Cancer Institute
Incyte Corporation
Shenzhen TargetRx Co., Ltd.
Baylor College of Medicine
Baylor College of Medicine
Florida International University
Enliven Therapeutics
American Regent, Inc.
M.D. Anderson Cancer Center
Shenzhen TargetRx Co., Ltd.
Orca Biosystems, Inc.
National Cancer Institute (NCI)
Shenzhen TargetRx Co., Ltd.
Shenzhen TargetRx Co., Ltd.
M.D. Anderson Cancer Center
Duke University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Kyowa Kirin Co., Ltd.
Novartis
OHSU Knight Cancer Institute
Sumitomo Pharma America, Inc.
Case Comprehensive Cancer Center
Karyopharm Therapeutics Inc
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Indiana University
Xencor, Inc.
University of Southern California
Medigene AG
H. Lee Moffitt Cancer Center and Research Institute